Found 29 matching trials
Phase Ib/II Clinical Study of SHR-8068 Combined Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom PHASE1 This study evaluated the safety and efficacy of SHR-8068 in combination ant...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma PHASE1 The study is being conducted to evaluate the safety, tolerability and effic...
Show More Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Learn More & Join Trial
A Phase II Clinical Study of FH-006 for Injection Combined With Other Anticancer Therapies in Subjects With Lung Cancer PHASE2 Evaluate the safety, tolerability, pharmacokinetics, and immunogenicity of ...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors PHASE2 The study is being conducted to evaluate the safety, tolerability and effic...
Show More Location
Affiliated Cancer Hospital of Shandong First Medical University
Learn More & Join Trial
A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLC PHASE2 This study is an open-label, multicenter Phase II clinical trial to evaluat...
Show More Location
Chinese People's Liberation Army (PLA) General Hospital
Learn More & Join Trial
SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer PHASE1 This study is a multicentre, open-label, dose-finding/efficacy-expanding ph...
Show More Location
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial
A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma PHASE1 The study is being conducted to evaluate the safety, tolerability and effic...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer PHASE1 This study is a multicenter, open-label, dose-finding/efficacy-expanding Ph...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract Cancer PHASE2 Cohort A and B: This cohort aims to evaluate the efficacy and safety of SHR...
Show More Status
Active Not Recruiting
Location
Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Learn More & Join Trial
Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma PHASE1 To evaluate the tolerability and safety of SHR-8068 in combination with Ade...
Show More Location
Anhui Provincial Hospital Ethics Commitee
Learn More & Join Trial